Platform revenue grew 15% but management guided 20% total growth with no acquisition cushion. The gap ships in the second half.
Thesis: secureWISE installed in 99.5% of 300mm fabs and $254M backlog give real visibility, but organic Platform growth of 15% needs a 5-point acceleration to hit the 20% guide with no acquisition help. The acceleration rests on products management defers to H2 while CapEx of $33M generates negative FCF of $9M. The platform moat is real. The near-term earnings quality is not clean.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: eProbe fleet nearly doubling from 6 to 12 machines with subscription conversion, and DRAM pilot contracts with 1-2 customers converting to revenue in 2026.
Key Risk: Operating cash flow of $24M against $33M CapEx produces negative FCF while carrying $68M debt. If OCF does not increase materially in 2026 as guided, the balance sheet forces a CapEx cut that slows installed base growth.
The Tell: CEO Kibarian said 'particularly in the second half of the year' twice when asked about IDM/fabless catalysts and forward growth drivers. This unprompted deferral reveals H1 visibility is weak. He also volunteered that OSAT integration is 'the longer pole in the tent' and Sapience selling expectation is generic. Delivered metrics are precise. Forward commitments are hedged.
Friction Level: MODERATE_FRICTION — Both sides agree on 94% recurring, $254M backlog, and 76% gross margin. Disagreement is whether 15% organic Platform growth can accelerate to 20% on products management defers to H2, with $33M annual CapEx producing negative FCF.
2025Q4 · Feb 12, 2026
5 of 5 readings agreed5 HOLDRead the full call
15% Organic Growth Guided to 20% on Products Landing in H2
secureWISE installed in 99.5% of 300mm fabs and $254M backlog give real visibility, but organic Platform growth of 15% needs a 5-point acceleration to hit the 20% guide with no acquisition help. The acceleration rests on products management defers to H2 while CapEx of $33M generates negative FCF of $9M. The platform moat is real. The near-term earnings quality is not clean.
CEO Kibarian said 'particularly in the second half of the year' twice when asked about IDM/fabless catalysts and forward growth drivers. This unprompted deferral reveals H1 visibility is weak. He also volunteered that OSAT integration is 'the longer pole in the tent' and Sapience selling expectation is generic. Delivered metrics are precise. Forward commitments are hedged.
Management claims 22% growth consistent with guidance, but Platform revenue grew only 15% organically. The 22% includes secureWISE acquisition revenue. The 2026 guide of 20% with 'no inorganic benefit' requires organic acceleration from 15% to 20% on products deferred to H2.
$254M backlog covers 14 months, but Volume-based revenue of $9.9M per quarter (Gainshare, secureWISE usage) sits outside backlog. Gainshare is tied to customer yield and volume, making it cyclical rather than contractual. Kibarian confirmed: 'The Volume revenue is typically not in our backlog.'
Exensio Studio AI is a licensed copy of Intel's Tiber AI Studio (formerly cnvrg.io), not built in-house. Sapience Manufacturing Hub has 'multiple contracts' but management refused to quantify revenue. Both are bundled into the 20% growth narrative without contribution figures.
New Platform vs Volume-based and Recurring vs Upfront taxonomy introduced at December Analyst Day highlights the 94% recurring figure while Upfront revenue declined YoY. The Q4 2024 comparison benefits from a one-time CapEx DirectScan sale.
DRAM pilots with 1-2 customers have zero contracted or quantified revenue. CEO says 'we expect that to ramp up this year.' Sapience selling timeline is multi-year ('longer pole in the tent' for OSAT integration). Confidence on delivered results, deferral on forward execution.
Q4 revenue of $62.4M beat prior year by 25%. FY $219M up 22%. Gross margin 77% Q4 exceeded the 75% old target. Management raised margin targets to 77% gross and 27% operating before fully delivering the old targets. Backlog of $254M exceeds annual revenue.
secureWISE in 99.5% of 300mm fabs globally. 8,000+ tools shipped with Cimetrix Connectivity, more than any single equipment vendor. Cimetrix runtime record revenue. Integration into fab operations creates high switching costs across equipment vendor and fab relationships.
Gross margin expanded from mid-60s to 76% since 2020. Q4 hit 77%. Operating margin 21% FY vs 20% target. OpEx growth managed below revenue growth (R&D +23%, SG&A +14% vs revenue +22%). Targets raised to 77% gross and 27% operating.
Management committing $33M annual CapEx for DirectScan/eProbe machines, shipping on subscription to build installed base. CEO: 'even if we stay at this level, but keep machines on subscriptions, you get this installed base of machines over time that all contribute.'
-20
CAUTIOUS"CEO uses 'particularly in the second half of the year' twice for forward catalysts, 'we expect to' and 'we anticipate' for DRAM pilots and eProbe deployment. CFO refuses to quantify Sapience revenue. Delivered results confident, forward commitments deferred."
Specific numbers on backlog, margins, revenue disaggregation, CapEx, debt, and installed base. Gaps: no quantification of Sapience or DRAM revenue, no secureWISE vs organic volume-based split, no free cash flow bridge.
eProbe fleet nearly doubling from 6 to 12 machines with subscription conversion, and DRAM pilot contracts with 1-2 customers converting to revenue in 2026.
Operating cash flow of $24M against $33M CapEx produces negative FCF while carrying $68M debt. If OCF does not increase materially in 2026 as guided, the balance sheet forces a CapEx cut that slows installed base growth.
“We finished the year strong with Q4 total revenues of $62.4 million versus $50.1 million in the same quarter a year prior.”
Figures are extracted from the transcripts and checked in code: every quote appears word for word. Descriptive only: none of this feeds the verdict.
Backlog of $254M against $219M annual revenue gives 14 months of cover. 94% recurring with 80%+ Platform revenue. secureWISE sits in 99.5% of 300mm fabs worldwide, 8,000+ tools shipped with Cimetrix Connectivity. Gross margin 77% Q4 with targets raised to 77% gross and 27% operating. Management raised the bar on themselves before fully delivering old targets. eProbe installed base doubling from 6 to 12 machines on subscription. DRAM pilots with positive results ramping in 2026 as 3D DRAM and wafer bonding demand electrical inspection PDF uniquely provides. Volume-based revenue grew 70% tied to customer fab utilization. $33M CapEx builds installed base that compounds on subscription. Platform compounder mispriced as project shop.
OCF of $24M against CapEx of $33M produces negative FCF of $9M while reporting $0.94 EPS. Net debt $26M after $130M secureWISE acquisition funded with $70M borrowing. Organic Platform growth was 15%, below the 20% target. The 22% headline includes acquisition revenue. 2026 guide of 20% with no inorganic requires organic acceleration from 15% with products deferred to H2. Exensio Studio AI is licensed Intel code. Sapience revenue unquantified. Volume-based revenue outside backlog is cyclical tied to customer yield. Upfront revenue declining. DRAM pilots have zero contracted revenue. $33M annual CapEx is permanent, not transitional.
Say/Do Gap
Platform revenue grew 15% organically. Management presents 22% total growth as 'consistent with guidance.' The 2026 guide of 20% without acquisition requires a 5-point organic acceleration on products management explicitly defers to the second half.
Backlog Quality
$254M backlog looks like 14 months of cover, but $38M of annual Volume-based revenue (Gainshare, secureWISE usage) sits outside backlog. Gainshare tracks customer yield and volume, making it cyclical. Kibarian confirmed volume revenue has no backlog.
AI Label Without Substance
Exensio Studio AI is licensed source code from Intel's Tiber AI Studio, not proprietary. Sapience Manufacturing Hub has 'multiple contracts' but CFO and CEO both refused to quantify revenue contribution. Both are part of the growth narrative without proof.
Mix Shift Spin
New revenue taxonomy introduced at December Analyst Day emphasizes 94% recurring while Upfront revenue declined YoY. The prior-year comparison includes a one-time CapEx DirectScan sale, flattering the comparison and masking the upfront decline.
Unsustainable Trend Confidence
DRAM pilots with 1-2 customers have no contracted or quantified revenue. CEO says 'we expect that to ramp up.' OSAT integration described as 'the longer pole.' Forward confidence rests on unproven pilots and multi-year timelines.
HOLD at medium conviction. The platform moat is real: secureWISE in 99.5% of 300mm fabs, 94% recurring, $254M backlog, 76% gross margin expanding. But organic Platform growth of 15% against a 20% guide with H2-dependent products is a real gap, and negative FCF of $9M with $68M debt and $33M permanent CapEx limits upside sizing. Wait for Q1 to see if OCF improves as CFO guided and whether H1 bookings confirm the H2 ramp. If OCF inflection shows and organic Platform accelerates above 18%, upgrade to LONG. If FCF stays negative through H1, downgrade to AVOID.